High Risk Hematological Malignancy
1 clinical trials · Condition
◉ Watch High Risk Hematological Malignancy
| Record | Firm | Date |
|---|---|---|
| US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia (NCT04103879) | ExCellThera inc. | 2020-11-13 |
Track High Risk Hematological Malignancy automatically
Every clearance here is in the API, with alerts when new ones post.